Clinical Trial Update: First-time-in-human (FTIH) Study of GSK3145095 Alone and in Combination With Other Anticancer Agents in Adults With Advanced Solid Tumors [Phase 2]

View source ↗

Summary

Phase 2 first-in-human study of GSK3145095 alone and in combination with other anticancer agents in adults with advanced solid tumors, terminated with posted re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neoplasms Pancreatic
• Pancreatic Cancer

Drugs mentioned

• GSK3145095

Snippet

Sponsor: GlaxoSmithKline | Conditions: Neoplasms, Pancreatic | Phase 2 | Status: TERMINATED | Results posted: 2020-07-31